Navigation Links
Designing Controls for siRNA ,,, Experiments


Because of its apparent specificity, reproducibility, and ease of use, RNAi technology is greatly accelerating the functional characterization of disease-relevant genes for drug discovery, target validation, and basic research efforts. To ensure the validity of RNAi data, however, proper experimental design and controls are needed. This article outlines some of the critical parameters for performing RNAi experiments in mammalian cultured cells.


Tips for Experimental Design

Carefully Choose Your siRNA Sequence for Maximum Specificity.
Although data indicate that siRNAs are highly specific, it is important to minimize the possibility of off-target effects by designing siRNAs that have limited sequence similarity to genes other than their intended target. Currently, it is not clearly understood how the number and location of mismatches between the antisense siRNA strand and the target mRNA affect silencing. Some reports indicate that a single mismatch in the center of an siRNA sequence can abolish silencing effects (1,2). In fact, this remarkable specificity has been shown in a model system to permit allele specific gene silencing (2). In contrast, another report indicates that siRNAs with regions of 14-15 contiguous bases of sequence similarity between the siRNA and an mRNA can induce silencing (3). Until we develop a better understanding of the specificity of siRNAs for their targets, it is best to design siRNAs that are completely complementary to the mRNA target and that contain at least 2 or more mismatches to all off target mRNAs. Also, results obtained with pools or populations of siRNAs should be confirmed with individual siRNAs to enhance the confidence level in the data.

Use the Minimum siRNA Concentration Required to Achieve Silencing.
Recent reports indicate that siRNA concentrations of 100 nM or higher in mammalian cultured cells can lead to nonspecific changes in gene expression (3,4). In general, transfecting 5-20 nM of an efficacious siRNA appears to minimize nonspecific effects while providing maximal target gene silencing. The concentration of siRNA required will depend upon the method and efficiency of siRNA delivery, the cell line used, and the effectiveness of the siRNA sequence.


Suggested Experimental Controls

Ambion scientists use and recommend a number of different controls for siRNA experiments. Most of these coincide with the suggested controls detailed in a recent editorial published in Nature Cell Biology (5). These controls can be used in virtually any gene silencing experiment, whether the effects are analyzed one gene at a time using more traditional mRNA and protein analysis techniques or on a genome-wide scale using microarrays.

Scrambled siRNA Control
A scrambled siRNA control is used to discount any changes to the gene expression profile that may result from the siRNA delivery method. Comparing cells transfected with a scrambled siRNA control to untransfected cells can reveal changes caused by siRNA delivery.

Positive siRNA Control
Ambion scientists always include a positive siRNA control in their experiments -- usually the Silencer GAPDH siRNA -- which serves to monitor siRNA transfection efficiency. When the positive control fails to elicit the expected reduction in gene expression, poor transfection is immediately suspected.

Multiple siRNAs to a Single Target
One of the best ways to increase confidence in data from siRNA experiments is to use two or more siRNAs to a single gene target. The siRNAs should first be analyzed for effectiveness at reducing target gene expression. Different siRNAs to the same gene with comparable gene silencing efficacy should induce similar changes in gene expression profile and phenotype. Any changes induced by one siRNA and not the other(s) could be attributed to off target effects. This approach is also valid for siRNA cocktails. In other words, cocktails prepared from different regions of the same gene can be used to confirm gene silencing results.

Monitor the Antiviral Response
Recent evidence indicates that up-regulation of the antiviral response may be a useful indicator of nonspecific siRNA effects. Although we do not yet routinely monitor the antiviral response in our own experiments, there are several published reports on how this response can be detected. One way is to assess levels of 2'5'-oligoadenylate synthetase mRNA (6). 2'5' oligoadenylate synthetase catalyzes the synthesis of 2'-5' polyadenylic acid, which activates the nonspecific ribonuclease RNase L. Another way is to monitor activation of the dsRNA-dependent protein kinase, PKR, which is involved in the type 1 interferon response. PKR phosphorylates the small subunit of the eukaryotic initiation factor 2-alpha (eIF2alpha), which results in nonspecific inhibition of translation. PKR activation can therefore be examined by monitoring the phosphorylation of eIF2alpha (7).

Monitor Both Target mRNA and Protein Levels
In siRNA experiments it may be beneficial to monitor both mRNA and protein levels for several reasons. For instance, mRNA reduction seen without a corresponding reduction in protein levels can indicate that protein turnover is slow. Furthermore, protein reduction in the absence of mRNA reduction may indicate that an siRNA is mediating its effects at the translational level like a microRNA.

The use of RNAi has enormous potential for analyzing gene function, elucidating biological pathways, and identifying and validating potential drug targets. The RNAi field is still in its infancy, and recommendations on experimental design and proper controls are likely to evolve. Ambion is committed to bringing researchers around the world the most up-to-date information on RNAi for their own research. For the latest information, see the RNAi Resource.


back to top


'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Designing a Successful qRT-PCR Experiment
2. Designing a Better siRNA
3. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
4. RNAi: The Controls You Need
5. Custom and library siRNA for efficient gene silencing
6. Custom and library siRNA for efficient gene silencing
7. Cancer siRNA Oligo Set Version 1.0
8. Library siRNA
9. Custom siRNA Oligo Synthesis Service
10. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
11. Quantification of siRNA Silencing Efficiency Using the LightCycler System
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Designing Controls for siRNA Experiments

(Date:12/24/2014)... December 23, 2014 According to Ross Selinger, ... Affiliate of ITRA Global, the national office market continues to ... This is evidenced by the third quarter’s surprising 3.9% ... Low energy costs have held inflation down and the ... is the housing market remaining soft. , This solid economic ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Pipette.com announces ... their Twitter followers can submit their #HolidayInTheLab pictures for ... their lab mates. , For those struggling to think ... the Pipette.com Holiday in the Lab Contest provides the ... Twitter followers to send pictures of their chemistree, ...
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich ... that the waiting period under the Hart-Scott-Rodino Antitrust ... acquisition expired on December 22, 2014, thereby completing ... requirement for the acquisition of the Company by ... antitrust clearance satisfies another condition to closing the ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
Breaking Biology Technology:ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... PURE Bioscience (OTC,Bulletin Board: PURE), creators of patented ... revolutionary new hard surface,disinfectant which kills Staph/MRSA as ... will present at the Biocom Investor Conference,on Thursday, ... Del Mar. Michael L.,Krall, CEO, will discuss the ...
... Pharmasset, Inc.,(Nasdaq: VRUS ) management will be presenting at the ... & Renshaw 9th Annual Healthcare Conference being ... in New York City. Schaefer Price, ... provide an overview of the company on Tuesday, ...
... EMERYVILLE, Calif., Oct. 26 Bionovo, Inc.,(Nasdaq: BNVI ) ... of 10,000,000 shares of common stock at a price to ... shares of common stock,at $3.50 per share at a price ... to the underwriters to purchase up to an additional 15% ...
Cached Biology Technology:PURE Bioscience to Present at Biocom Investors Conference 2PURE Bioscience to Present at Biocom Investors Conference 3PURE Bioscience to Present at Biocom Investors Conference 4Pharmasset to Present at Three Investor Conferences in November 2007 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 3
(Date:12/22/2014)... Research and Markets ( ... the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 ... the global digital media watermarking and fingerprinting ... piracy by securely and invisibly embedding identifiable ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ... to expand its team and bring LaunchKey to market ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research ... announced the addition of the "Global Chemical ... http://photos.prnewswire.com/prnh/20130307/600769 ... is the increasing demand for medical sensors in ... patient data for quick and correct diagnosis during ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... this week in The Lancet Infectious Diseases ... bacterial infection that causes pneumonia, meningitis and sepsis ... a blood disorder prevalent in African children that increases ... study underscores the critical need for use of pneumococcal ...
... Could one of South America,s greatest military figures ... tuberculosis assumed at the time of his death in ... known as "El Libertador" or "The Liberator" ... Historical Clinicopathological Conference (CPC), sponsored by the University of ...
... 2010) Eighty percent of health problems and five million ... water and sanitation according to the World Water Development Report ... for rural villagers, highlights a dire need for reliable access ... aims to solve. The Lemelson-MIT Program today announced ...
Cached Biology News:Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 2Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 3Historic medical conference finds Bolivar may have been poisoned 2Historic medical conference finds Bolivar may have been poisoned 3Historic medical conference finds Bolivar may have been poisoned 4Inventor honored for tech improving access to clean water, healthcare, and business development in India 2Inventor honored for tech improving access to clean water, healthcare, and business development in India 3Inventor honored for tech improving access to clean water, healthcare, and business development in India 4